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Abstract
Background: Although there has been marked development in surgical techniques, there is no easy and fast
method of predicting complications in minimally invasive surgeries. We evaluated whether the modified surgical
Apgar score (MSAS) could predict perioperative complications in patients undergoing robotic-assisted radical
hysterectomy.
Methods: All patients with cervical cancer undergoing robotic-assisted radical hysterectomy at our institution
between January 2011 and May 2017 were included. Their clinical characteristics were retrieved from their medical
records. The surgical Apgar score (SAS) was calculated from the estimated blood loss, lowest mean arterial pressure,
and lowest heart rate during surgery. We modified the SAS considering the lesser blood loss typical of robotic
surgeries. Perioperative complications were defined using a previous study and the Clavien-Dindo classification and
subdivided into intraoperative and postoperative complications. We analyzed the association of perioperative
complications with low MSAS.
Results: A total of 138 patients were divided into 2 groups: with (n = 53) and without (n = 85) complications.
According to the Clavien-Dindo classification, 49 perioperative complications were classified under Grade I (73.1%);
13, under Grade II (19.4%); and 5, under Grade III (7.5%); 0, under both Grade IV and Grade V. Perioperative
complications were significantly associated with surgical time (p = 0.026). The MSAS had a correlation with
perioperative complications (p = 0.047). The low MSAS (MSAS, ≤6; n = 52) group had significantly more
complications [40 (76.9%), p = 0.01]. Intraoperative complications were more correlated with a low MSAS than were
postoperative complications [1 (1.2%) vs. 21 (40.4%); p < 0.001, 13 (15.1%) vs. 25 (48.1%); p = 0.29, respectively]. We
also analyzed the risk-stratified MSAS in 3 subgroups: low (MSAS, 7–10), moderate (MSAS 5–6), and high risks
(MSAS, 0–4). The prevalence of intraoperative complications significantly increased as the MSAS decreased p = 0.01).
Conclusions: This study was consistent the concept that the intuitive and simple MSAS might be more useful in
predicting intraoperative complications than in predicting postoperative complications in minimally invasive
surgeries, such as robotic-assisted radical hysterectomy for cervical cancer.
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Background
Telerobotic surgery has been introduced in the field
of gynecology and contributed to great progress in
surgical management. Since the introduction of
radical hysterectomy using robots in patients with
early-stage cervical cancer, robotic-assisted radical
hysterectomy has been rapidly adopted in gynecologic
oncology. Robotic-assisted radical hysterectomy yields
a shorter surgical time, lesser blood loss, shorter
hospital stay, faster recovery, less postoperative pain,
and fewer complications than does traditional abdom-
inal radical hysterectomy and laparoscopic-assisted
radical hysterectomy [1–3]. Although there has been
marked development in surgical techniques, there is
no easy and fast method of predicting complications
in minimally invasive surgeries. Predicting postopera-
tive complications improves the quality of care by
increasing patient satisfaction and reducing the re-
admission rate and medical resource wasting [4].
In 1953, the neonatal Apgar score was introduced
and has brought a considerable change the predic-
tion of neonatal outcomes [5]. Gawande et al.
devised the surgical Apgar score (SAS) based on this
concept and applied it to general or vascular surgery
[6]. The SAS, a 10-point scoring system, comprises 3
components: estimated blood loss (EBL), mean arter-
ial pressure (MAP), and heart rate (HR) during
surgery. The SAS ranges from 0 to 10; a low SAS
indicates poor outcomes as in the neonatal Apgar
score.
Since its introduction, the SAS has been validated
for its usefulness in surgical fields, including urologic,
head and neck, neurosurgical, orthopedic, transplant,
and gastrointestinal surgeries [7–15]. It has also been
used in gynecologic oncology. Low SASs (≤4) were
reported as a strong predictor of postoperative com-
plications after cytoreduction for advanced ovarian
cancer [16]. The SAS was applied to elderly patients
who underwent non-laparoscopic surgery and was
confirmed its usefulness [17]. Low SASs were associ-
ated with morbidity but were unable to predict post-
operative complications in patients undergoing
hysterectomy for malignancy [18]. This controversy
exists in other studies. Most studies have reported
that the SAS was useful in predicting postoperative
complications; however, other studies could not con-
firm this association [9, 19, 20]. All previous studies
on the SAS have been conducted in laparotomy sur-
gery; no study has used this on minimally invasive
surgeries, which are currently replacing traditional
surgical approaches. We sought to evaluate whether
the SAS could predict perioperative complications in
patients undergoing robotic-assisted radical hysterec-
tomy for cervical cancer.
Methods
All patients with cervical cancer undergoing robotic
radical surgery at our institution between January 2011
and May 2017 were included. All final diagnoses were
confirmed by our gynecologic pathologists. Patients were
excluded if they had incomplete medical records. Radical
hysterectomy or trachelectomy (and/or bilateral pelvic
lymph node dissection, paraaortic lymph node dissec-
tion, and/or bilateral salpingo-oophorectomy) was per-
formed depending on the stage and fertility preservation
of the patients. Data were retrieved from the patients’
medical records (inpatient and outpatient, pathologic,
anesthetic, and surgical records). We collected data on
the patients’ demographics, perioperative complications,
and SAS.
Perioperative complications were defined as described
by previous study and the Clavien-Dindo classification,
and subdivided into intraoperative and postoperative
complications [1]. Postoperative complications included
fever (> 37.8 °C) for > 24 h postoperatively, urinary dis-
tention, ileus, vault bleeding, readmission within 30 days
after surgery, lymphedema, nerve palsy, wound dehis-
cence, fistula, and peritonitis. Intraoperative complica-
tions included transfusion within 72 h after surgery,
large blood loss amount (≥300 mL), and organ injury.
The SAS was calculated from the EBL, lowest MAP,
and lowest HR. Because the EBL of the SAS was set for
open surgery, applying it to minimally invasive surgeries
was difficult. Thus, we applied the modified SAS
(MSAS) based on the lesser blood loss typical of robotic
surgeries (Table 1). The lowest HR and MAP were
obtained from the anesthetic records. During surgery,
the patients’ vital signs were recorded on an anesthesia
record every 5 min. The EBL was obtained from the sur-
gical records. The surgical team (surgeon, nurse, and
anesthesiologist) evaluated blood loss after surgery and
recorded it on the surgical note. We also analyzed the
risk-stratified MSAS in 3 subgroups: low (MSAS, 7–10),
moderate (MSAS, 5–6), and high risks (MSAS, 0–4).
Clinical variables were compared using Student’s
t-test as appropriate for univariate analysis. Categorical
variables were compared using Chi-square test and
Fisher’s exact test. Significantly associated variables
were analyzed utilizing the linear-by-linear association
test. Data were shown as means [± standard devia-
tions (SDs)], medians (ranges), and numbers of
patients (%), where applicable. For all statistical
analyses, p-values < 0.05 were considered statistically
significant. Statistical analysis was performed using
SPSS version 23.0 (Chicago, Illinois, USA).
Results
Between January 2011 and May 2017, 148 patients
underwent robotic-assisted radical surgery for cervical
Park et al. BMC Cancer  (2018) 18:908 Page 2 of 7
cancer at our institution; 10 of them had incomplete
medical records. Thus, a total of 138 patients were fi-
nally enrolled. Twenty-one patients (17.95%) underwent
robotic-assisted radical trachelectomy, and 117 patients
(82.05%) underwent RRH. In this cohort, 53 patients
(38.4%) had a total of 67 perioperative complications; 27
patients (19.6%) had intraoperative complications; 38
patients (27.5%), postoperative complications; and 12
patients (8.7%), both. According to the Clavien-Dindo
classification, 49 perioperative complications were classi-
fied under Grade I (73.1%); 13, under Grade II (19.4%);
and 5, under Grade III (7.5%); 0, under both Grade IV
and Grade V. Table 2 shows the perioperative complica-
tions details.
The patients’ clinical characteristics and MSASs are
summarized in Table 3. The mean age and body mass
index (BMI) were not significantly different between the
groups. Neoadjuvant chemotherapy (NAC) before sur-
gery [4 (4.7%) vs. 3 (5.8%); p = 0.77] and surgical radical-
ity were also not significantly different (p = 0.47).
Perioperative complications were significantly associated
with surgical time (p = 0.026). The SAS was also not sig-
nificantly different; however, the MSAS was associated
with perioperative complications (p = 0.047).
Table 4 shows the correlation of the complications
with a low MSAS (MSAS, ≤6). In the total cohort, 52
patients (36.7%) had an MSAS of ≤6, and 86 patients
(62.3%) had an MSAS of > 6. We did not find an associ-
ation between a low MSAS and age, BMI, underlying
disease, previous pelvic surgery, NAC, and extensive sur-
gical procedures. The preoperative hemoglobulin level
was higher in the low MSAS group than in the high
MSAS group [mean (SD): 13.2 (±1.2) vs. 12.6 (±1.2);
p = 0.01]. The low MSAS group had significantly more
complications [40 (76.9%), p = 0.01]. The intraoperative
complications were more correlated with a low MSAS
than the postoperative complications [1 (1.2%) vs. 21
(40.4%); p < 0.001, 13 (15.1%) vs. 25 (48.1%); p = 0.29,
respectively].
In the low MSAS group, perioperative complications oc-
curred in 40 (76.9%) patients; intraoperative complications
in 26 (50%) patients; and postoperative complications in
25 (48.1%) patients. Table 5 shows the association between
a low MSAS and operative complications; a low MSAS
was not significantly associated with perioperative [odds
ratio (OR), 1.43; p = 0.36] and postoperative complications
(OR, 0.711; p = 0.4). However, a low MSAS was a
Table 1 Original SAS and MSAS
0 points 1 point 2 points 3 points 4 points
SAS
EBL (mL) > 1000 601–1000 101–600 ≤100 _
Lowest MAP (mmHg) < 40 40–54 55–69 ≥70 _
Lowest HR (beats/min) > 85 76–85 66–75 55–65 ≤55
MSAS
EBL (mL) > 300 151–300 51–150 ≤50 _
Lowest MAP (mmHg) < 40 40–54 55–69 ≥70 _
Lowest HR (beats/min) > 85 76–85 66–75 55–65 ≤55
SAS surgical Apgar score, MSAS modified surgical Apgar score, EBL estimated blood loss, MAP mean arterial pressure, HR heart rate




Grade I 49 73.1
Grade II 13 19.4
Grade III 5 7.5
Grade IV 0 0
Grade V 0 0
Perioperative complicationsb
Intraoperative complications
Bleeding (≥300 mL) 16 11.59
Transfusion 10 7.25
Bowel injury 1 0.72
Bladder or ureter injury 1 0.72
Postoperative complications
Fever for > 24 h 17 12.32
Urinary distention 6 4.35
Ileus 3 2.17
Vault bleeding 2 1.45
Readmission at < 30 days 2 1.45
Lymphedema 2 1.45
Dysrhythmia 2 1.45
Nerve palsy 2 1.45
Wound dehiscence 1 0.72
Fistula 1 0.72
Peritonitis 1 0.72
aIn relation to the total number of complications (n = 67)
bIn relation to the total number of patients (n = 138)
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predictor for intraoperative complications (OR, 3.57; 95%
confidence interval: 1.0–12.7; p = 0.039) (Table 5).
The linear-by-linear association test results for the
perioperative and intraoperative complications with the
risk-stratified MSASs are described in Fig. 1. The
number of patients with perioperative complications was
7/15 (46.7%) in the low-risk group, 32/90 (35.6%) in the
moderate-risk group, and 14/33 (42.4%) in the high-risk
group. Among the patients with intraoperative compli-
cations, 0/15 (0%) were included in the low-risk
group; 15/90 (16.7%) in the moderate-risk group; and
10/33 (30.3%) in the high-risk group. We could not
confirm the significance of the increased prevalence of
perioperative complications with the decreased MSAS
(p = 0.98). However, the intraoperative complications
significantly increased as the MSAS decreased (p = 0.01).
The patients with increasing risk-stratified MSASs had a
higher incidence of intraoperative complications.
Discussion
The current study showed that a low MSAS could pre-
dict perioperative complications in patients undergoing
robotic-assisted radical hysterectomy. This supports the
findings of previous studies that validated the usefulness
of the SAS in predicting perioperative complications
after major surgeries [16, 17]. The EBL scale in the SAS
was slightly modified account for the lesser blood loss in
robotic-assisted surgeries. A previous study also
employed the modified EBL scale because of the larger
blood loss and showed that the SAS could predict major
Table 3 Patients’ clinical characteristics and MSAS
Complication P-value
No (n = 85) Yes (n = 53)
Age (years) 44.1 (±10.1) 43.1 (±9.8) 0.51
BMI (kg/m2) 22.9 (±3.0) 22.9 (±3.3) 0.98
Underlying disease (n) 17 (20.0) 7 (13.2) 0.31
Previous pelvic surgery (n) 35 (41.2) 18 (33.7) 0.40
Surgical time (min) 190.0 (±70.9) 221.0 (±90.0) 0.026
Preoperative Hb (g/dL) 13.0 (±1.20) 12.6 (±1.3) 0.10
Postoperative Hb (g/dL) 12.8 (±1.3) 11.0 (±1.3) 0.27
NAC (n) 4 (4.7) 3 (5.8) 0.77
Surgical procedure (n) 0.47
Radical trachelectomy (±BPLD and PALND) 12 (14.1) 9 (17.0)
Radical hysterectomy (±BPLD, PALND, and BSO) 73 (85.9) 44 (83.0)
SAS 7.4 (±1.1) 7.1 (±1.3) 0.27
MSAS 7.0 (±1.2) 6.5 (±1.8) 0.047
MSAS modified surgical Apgar score, BMI body mass index, Hb hemoglobulin, NAC neoadjuvant chemotherapy, BPLD bilateral pelvic lymph node dissection,
PALND paraaortic lymph node dissection, BSO bilateral salpingo-oophorectomy, SAS surgical Apgar score
Data are presented as means (± standard deviations) or as numbers of patients (%)
Table 4 Characteristics of the patients with low MSASs
MSAS of > 6 (n = 86) MSAS of ≤6 (n = 52) P-value
Age (years) 43.1 (±9.9) 44.7 (±10.1) 0.37
BMI (kg/m2) 22.7 (±2.9) 23.3 (±3.8) 0.27
Underlying disease (n) 15 (17.4) 9 (17.3) 0.98
Previous pelvic surgery (n) 36 (41.9) 17 (32.7) 0.29
NAC (n) 4 (4.7) 3 (5.8) 0.77
Radicality of surgery 0.33
Preoperative Hb (g/dL) 12.6 (±1.2) 13.2 (±1.2) 0.012
Perioperative complications (n) 13 (15.1) 40 (76.9) 0.01
Intraoperative complications (n) 1 (1.2) 26 (50) < 0.001
Postoperative complications (n) 13 (15.1) 25 (48.1) 0.29
MSAS modified surgical Apgar score, BMI body mass index, NAC neoadjuvant chemotherapy, Hb hemoglobulin
Data are provided as means (± standard deviations) or as numbers of patients (%)
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postoperative complications and death [7]. The differ-
ence between the current and previous studies is that
most of the latter defined low SASs as ≤4; conversely,
we defined it as ≤6 [17]. We thought that the lesser
blood loss, which is the strength of robotic-assisted
radical hysterectomy, had influenced our results.
Furthermore, our low MSAS definition reflects the risk
assessment system of the Apgar score better, which is
the basis of the SAS.
One study reported hospital readmissions within
30 days after discharge in 13.2% of 2455 patients in gy-
necologic oncology. Among them, 87% had gynecologic
malignancies and 22.2% had cervical cancer [4]. These
unplanned readmissions are more costly than planned
hospitalizations and yield lower medical care quality.
Therefore, clinicians strive to predict postoperative
complications using preoperative and intraoperative
assessment tools, such as the American Society of
Anesthesiologists Physical Status Classification System
(ASA classification) [21], Acute Physiology and Chronic
Health Evaluation (APACHE) [22], and Physiological
and Operative Severity Score for the enUmeration of
Mortality and Morbidity (POSSUM) [23]. However, the
ASA classification only reflects the patients’ preoperative
physical status and therefore does not reflect the
patients’ intraoperative conditions due to unexpected
complications during surgery. Because of the compli-
cated scoring system, the APACHE and POSSUM are
not widely used in clinical practice for postoperative risk
prediction [18, 24]. Complexity of surgical procedures,
elevated serum glutamic oxaloacetic transaminase levels,
higher ASA scores, and obesity were reported as risk
factors for adverse events in gynecological cancer sur-
gery [16, 25]. However, most patients with cervical can-
cer who can be treated surgically have no preoperative
underlying diseases and do not have these preoperative
risk factors. Therefore, intraoperative patient assessment
is an important factor for predicting postoperative com-
plications. For these reasons, surgeons need a useful tool
to evaluate the patients’ condition during urgent surger-
ies so that patients can receive appropriate postoperative
care.
The SAS could be easily applied in clinical practice
because it is a simple and intuitive scoring system. This
scoring system assesses intraoperative management
using only 3 objective factors (i.e., EBL, lowest HR, and
lowest MAP during surgery); the lower the score, the
higher the postoperative complication risk. The SAS is
easy to calculate, interpret, and apply. Because of these
attractive strengths, many researchers have been work-
ing on the clinical application of this new risk assess-
ment tool to predict postoperative complications. The
original study was conducted on patients who under-
went colectomy, and the subsequent validation studies
were conducted on large samples in other surgical fields.
The SAS was applied to 4119 general and vascular sur-
gery patients and demonstrated its usefulness [26]. The
past study confirmed the validity of the SAS in patients
from a low-income country who underwent laparotomy
[27]. Recently, a new surgical scoring system has been
proposed that combines intraoperative assessment of the
SAS and preoperative assessment of the ASA score to
predict postoperative mortality [28, 29]. Immediate
recognition of postoperative complications leads to care-
ful postoperative management, prevents postoperative
complications, and improves patient outcome [30].
Table 5 Low MSASs (≤6) as a predictor for intraoperative
complications
Odds ratio 95% CI P-value
For perioperative complications 1.43 0.7–3.1 NS
For intraoperative complications 3.570 1.0–12.7 0.039
For postoperative complications 0.711 0.3–1.6 NS
NS not significant, CI confidence interval
Fig. 1 Linear-by-linear association test results of the perioperative
and intraoperative complications with the risk-stratified MSAS. (a)
Association between perioperative complications and risk-stratified
MSAS; (b) association between intraoperative complications and
risk-stratified MSAS. The patients with increasing risk-stratified
MSASs have a higher incidence of intraoperative complications
(b) (p = 0.01). However, this association was not found in the
perioperative complications (a) (p = 0.98). MSAS, modified surgical
Apgar score
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Because the SAS reflects the intraoperative manage-
ment status, low MSASs have a higher correlation with
intraoperative complications. The patients with lower
MSASs had a higher incidence of intraoperative compli-
cations. The previous study defined perioperative com-
plications as blood transfusion after surgery and a large
blood loss amount during surgery [16]. We classified
perioperative complications into intraoperative and post-
operative complications and defined intraoperative com-
plications as blood transfusion, a large blood loss
amount, and organ injury.
One of the interesting findings of our study is that
only 1 patient received transfusion among the 16 pa-
tients with an EBL amount of ≥300 mL. Postoperative
transfusion was associated with lower MSASs rather
than was absolute blood loss amount. Three pillars of
transfusion in surgical patients were reported: detection
and treatment of preoperative anemia; reduction of peri-
operative blood loss; and harnessing and optimizing the
patient-specific physiological reserve of anemia [31, 32].
In addition to these 3 factors, our results showed that
proper intraoperative management is also important for
transfusion of surgical patients.
Our study has some limitations. First, this was a retro-
spective study conducted at a single tertiary academic
center, and data were collected only from patients with
cervical cancer undergoing robotic surgery. Second, the
HR and blood pressure were recorded every 5 min in
anesthesia records. Not all values were recorded during
surgery; however, according to the monitoring guideline
for safe anesthesia, vital signs were measured at least
every 5 min or more often, if necessary, so that blood
pressure and HR can be accurately assessed [17, 33]. Fi-
nally, our results were derived from a single disease and
single surgical procedure, with similar surgical radicalities.
Despite these limitations, to the best our knowledge,
this is the first study to investigate the MSAS in patients
undergoing robotic-assisted radical hysterectomy. Pre-
operative and intraoperative risk assessments are im-
portant for surgeons to provide adequate postoperative
care for patients. The 3 parameters could be useful for
intraoperative risk assessment in minimally invasive
surgeries. For the MSAS to be generally accepted, fur-
ther prospective studies should be performed in various
institutions and on various diseases and other minimally
invasive surgeries.
Conclusions
This study was consistent the concept that the intuitive
and simple MSAS might be more useful in predicting
intraoperative complications than in predicting postop-
erative complications in minimally invasive surgeries,
such as robotic-assisted radical hysterectomy for
cervical cancer.
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